| European Federation of Internal Medicine

Human medicines European public assessment report (EPAR): Aranesp, darbepoetin alfa, Date of authorisation: 08/06/2001, Revision: 46, Status: Authorised

Submitted by Anonymous (not verified) on 28 June 2024 - 12:36

Human medicines European public assessment report (EPAR): Aranesp, darbepoetin alfa, Date of authorisation: 08/06/2001, Revision: 46, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Aranesp, darbepoetin alfa, Date of authorisation: 08/06/2001, Revision: 46, Status: Authorised

Draft guideline on the conduct of efficacy studies for intramammary products for use in cattle

Submitted by Anonymous (not verified) on 28 June 2024 - 12:00

Draft guideline on the conduct of efficacy studies for intramammary products for use in cattle

Read more about Draft guideline on the conduct of efficacy studies for intramammary products for use in cattle

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 June 2024

Submitted by Anonymous (not verified) on 28 June 2024 - 11:01

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 June 2024

Read more about Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 June 2024

Summary of opinion: Vabysmo, 27/06/2024 Positive

Submitted by Anonymous (not verified) on 28 June 2024 - 11:00

Summary of opinion: Vabysmo, 27/06/2024 Positive

Read more about Summary of opinion: Vabysmo, 27/06/2024 Positive

Summary of opinion: Tepkinly, 27/06/2024 Positive

Submitted by Anonymous (not verified) on 28 June 2024 - 11:00

Summary of opinion: Tepkinly, 27/06/2024 Positive

Read more about Summary of opinion: Tepkinly, 27/06/2024 Positive

Summary of opinion: Beyfortus, 27/06/2024 Positive

Submitted by Anonymous (not verified) on 28 June 2024 - 11:00

Summary of opinion: Beyfortus, 27/06/2024 Positive

Read more about Summary of opinion: Beyfortus, 27/06/2024 Positive

Summary of opinion: Betmiga, 27/06/2024 Positive

Submitted by Anonymous (not verified) on 28 June 2024 - 11:00

Summary of opinion: Betmiga, 27/06/2024 Positive

Read more about Summary of opinion: Betmiga, 27/06/2024 Positive

Summary of opinion: Imcivree, 27/06/2024 Positive

Submitted by Anonymous (not verified) on 28 June 2024 - 11:00

Summary of opinion: Imcivree, 27/06/2024 Positive

Read more about Summary of opinion: Imcivree, 27/06/2024 Positive

Transfer of MA templates Attachment 6.1 (Superseded)

Submitted by Anonymous (not verified) on 28 June 2024 - 11:00

Transfer of MA templates Attachment 6.1 (Superseded)

Read more about Transfer of MA templates Attachment 6.1 (Superseded)

Orphan designation: sotatercept Treatment of pulmonary arterial hypertension, 09/12/2020 Positive

Submitted by Anonymous (not verified) on 28 June 2024 - 11:00

Orphan designation: sotatercept Treatment of pulmonary arterial hypertension, 09/12/2020 Positive

Read more about Orphan designation: sotatercept Treatment of pulmonary arterial hypertension, 09/12/2020 Positive

Newsletters

Stay informed on our latest news!

Latest Newsletters